BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Latest 3 SEC Filings
Initial statement of beneficial ownership of securities

OXIGENE INC, 3, 2000-12-13
APHTON CORP, 3, 2000-06-09
NOVAVAX INC, 3, 2000-03-28
DISCOVERY LABORATORIES INC /DE/, 3, 2000-02-24
ARIAD PHARMACEUTICALS INC, 3, 1999-12-23
GENTA INCORPORATED /DE/, 3, 1999-12-10
DISCOVERY LABORATORIES INC /DE/, 3, 1999-12-01
ORGANOGENESIS INC, 3, 1999-10-14
TEXAS BIOTECHNOLOGY CORP /DE/, 3, 1999-10-07
GENTA INCORPORATED /DE/, 3, 1999-09-08
ENZON INC, 3, 1999-07-12
HYBRIDON INC, 3, 1999-06-07
HYBRIDON INC, 3, 1999-05-20
GENTA INCORPORATED /DE/, 3, 1999-05-19
CORIXA CORP, 3, 1999-04-19
AUTOIMMUNE INC, 3, 1999-03-18
AVAX TECHNOLOGIES INC, 3, 1999-03-10
DISCOVERY LABORATORIES INC /DE/, 3, 1998-12-04
ORGANOGENESIS INC, 3, 1998-11-20
TREGA BIOSCIENCES INC, 3, 1998-11-17
OXIGENE INC, 3, 1998-11-10
ORGANOGENESIS INC, 3, 1998-09-28
PROCEPT INC, 3, 1998-09-10
DISCOVERY LABORATORIES INC /DE/, 3, 1998-08-19
MEDAREX INC, 3, 1998-08-14
DISCOVERY LABORATORIES INC /DE/, 3, 1998-08-11
MAGAININ PHARMACEUTICALS INC, 3, 1998-06-23
MEDAREX INC, 3, 1998-06-19
HYBRIDON INC, 3, 1998-05-29
SERAGEN INC, 3, 1998-05-21
AUTOIMMUNE INC, 3, 1998-05-01
ENZON INC, 3, 1998-03-18
BIOTIME INC, 3, 1998-02-18
DISCOVERY LABORATORIES INC /DE/, 3, 1998-02-17
GENTA INCORPORATED /DE/, 3, 1997-11-12
RIBI IMMUNOCHEM RESEARCH INC, 3, 1997-11-10
GENTA INCORPORATED /DE/, 3, 1997-10-03
GENTA INCORPORATED /DE/, 3, 1997-10-01
GENTA INCORPORATED /DE/, 3, 1997-09-30
GENTA INCORPORATED /DE/, 3, 1997-09-19
ARIS INDUSTRIES INC, 3, 1997-07-30
ARIS INDUSTRIES INC, 3, 1997-07-29
ANSAN PHARMACEUTICALS INC, 3, 1997-07-25
PROCEPT INC, 3, 1997-07-10
GENTA INCORPORATED /DE/, 3, 1997-07-10
AVAX TECHNOLOGIES INC, 3, 1997-07-08
INTERFERON SCIENCES INC, 3, 1997-06-24
ALFACELL CORP, 3, 1997-06-02
GENTA INCORPORATED /DE/, 3, 1997-05-27
ALFACELL CORP, 3, 1997-05-27
MAGAININ PHARMACEUTICALS INC, 3, 1997-03-10
SOMATIX THERAPY CORPORATION, 3, 1997-02-28
ENZON INC, 3, 1997-01-09
MAGAININ PHARMACEUTICALS INC, 3, 1996-09-16
ALFACELL CORP, 3, 1996-08-08


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission